Frazier Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Frazier Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.04K	Hold	115	–	–	﹤0.01%	549
2025 Q4	$3.33K	Hold	115	–	–	﹤0.01%	514
2025 Q3	$3.19K	Hold	115	–	–	﹤0.01%	495
2025 Q2	$2.8K	Hold	115	–	–	﹤0.01%	505
2025 Q1	$2.39K	Hold	115	–	–	﹤0.01%	489
2024 Q4	$2.73K	Hold	115	–	–	﹤0.01%	496
2024 Q3	$2.94K	Sell	115 -75	-39%	-$1.91K	﹤0.01%	644
2024 Q2	$4.46K	Hold	190	–	–	﹤0.01%	639
2024 Q1	$5.46K	Hold	190	–	–	﹤0.01%	577
2023 Q4	$6.23K	Buy	+190	New	+$5.17K	0.01%	452

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Frazier Financial Advisors's ARKG Position: Q1 2026 in Review

Frazier Financial Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 115 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Frazier Financial Advisors first reported a position in ARKG in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.23K in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Frazier Financial Advisors held 115 shares of ARK Genomic Revolution ETF worth $3.04K as of Q1 2026.
Frazier Financial Advisors left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #549 holding.
Frazier Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 10 quarters since.
Frazier Financial Advisors's ARK Genomic Revolution ETF position peaked at $6.23K in Q4 2023.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.